VanderPluym, C.J., Cedars, A., Eghtesady, P., Maxwell, B.G., Gelow, J.M., Burchill, L.J., et al. (2018) Outcomes Following Implantation of Mechanical Circulatory Support in Adults with Congenital Heart Disease: An Analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). The Journal of Heart and Lung Transplantation, 37, 89-99.
https://doi.org/10.1016/j.healun.2017.03.005

has been cited by the following article:

• TITLE: Heart Transplant at Seoul National University Hospital: Is It Reproducible in Sub-Saharan Africa?

  AUTHORS: Koutoua Eric Katche, Ahou Sarrah Assie, Jeanne Iris Degni, Dominique Sarra Arriko, Ahoua Gnita Kone, Lucien Asseke, Kwadjau Anderson Amani, Patrick Bogbe, Jean Calaire Degre, Aimé Kirioua-Kamenan, Junior Yeo, Kouassi Antonin Souaga, Woog-Han Kim

  KEYWORDS: Heart Transplantation, Heart Failure, Ventricular Assist Device

  JOURNAL NAME: World Journal of Cardiovascular Surgery, Vol.15 No.4, April 24, 2025

  ABSTRACT: Introduction: Heart transplantation is used to treat heart failure. The first human-to-human heart transplant took place in South Africa in 1967. However, this surgical technique is not practiced in sub-Saharan Africa, but heart failure is clearly increasing in the young and active African populations. We report the case of 03 heart transplants successfully performed in the pediatric cardiac surgery department at Seoul National University Hospital. Objective: To present heart transplantations for congenital heart disease in order to reproduce them technically in sub-Saharan Africa. Cases series: Case 1: Male, 3 years old. Background: main pulmonary artery (MPA) banding, Ventricular Septal defect (VSD) closure, Heart failure requiring left ventricular assist device (LVAD) implantation. Echocardiography: left ventricle dysfunction (EF 28%), Heart transplantation. The immediate postoperative follow-up was simple. Case 2: Male, 9 years old. Background: Dilated cardiomyopathy (DCMP), Left ventricular assist Device (LVAD) implantation. Echocardiography: Severe LV dysfunction, global akinesia, LV FS/EF 10.4/22.4% (PLAX). Heart transplantation. The immediate postoperative follow-up was simple. Case 3: Male, 20 years old. Background: dilated cardiomyopathy (DCMP), Duchenne Muscular Dystrophy (DMD), Left ventricular assisted device (L-VAD) (HeartMate 3) implantation. Echocardiography: Aggravated LV dysfunction (EF 26% - 29%). Heart transplantation. The immediate postoperative follow-up was simple. Conclusion: Heart transplantation according to the bi-caval procedure has made it possible to treat children with end-stage heart failure at Seoul National University Hospital. End-stage heart failure in Africa is clearly increasing among the young working population. Although Africa faces a range of challenges, heart transplantation is reproducible in sub-Saharan Africa.